How effective are current drug treatments for patients with myeloma kidney disease?
How the treatment of ALL is changing
Current therapy for CLL and the new monoclonal antibody ofatumumab
The role of blinatumomab in ALL
Current investigations in the use of allogeneic transplant in the treatment of myeloma